Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients.
Labarca
R
R
Silva
H
H
Jerez
S
S
Ruiz
A
A
Renterías
P
P
Ogalde
C
C
Bustos
G
G
D000293:Adolescent; D000328:Adult; D018492:Dopamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D018698:Glutamic Acid / Q000134:cerebrospinal fluid*; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D018492:Dopamine Antagonists; D018698:Glutamic Acid; D006220:Haloperidol